Literature DB >> 29177925

Genetics of pancreatic cancer and implications for therapy.

Priya Bhosale1, Veronica Cox2, Silvana Faria2, Sanaz Javadi2, Chitra Viswanathan2, Eugene Koay3, Eric Tamm2.   

Abstract

Pancreatic cancer is a highly lethal disease with a dismal 5-year prognosis. Knowledge of its genetics may help in identifying new methods for patient screening, and cancer treatment. In this review, we will describe the most common mutations responsible for the genesis of pancreatic cancer and their impact on screening, patterns of disease progression, and therapy.

Entities:  

Keywords:  Genomics; Imaging; Mutations; Pancreatic cancer

Mesh：

Year:  2018        PMID： 29177925     DOI： 10.1007/s00261-017-1394-y

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  4 in total

1.  Upregulation of DLC-1 inhibits pancreatic cancer progression: Studies with clinical samples and a pancreatic cancer model.

Authors:  Bo Chen; Mingzheng Xu; Ming Xu
Journal:  Oncol Lett       Date:  2019-09-16       Impact factor: 2.967

Review 2.  Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review.

Authors:  Qun Chen; Wu-Jun Wang; Yun-Xuan Jia; Hao Yuan; Peng-Fei Wu; Wan-Li Ge; Ling-Dong Meng; Xu-Min Huang; Peng Shen; Tao-Yue Yang; Yi Miao; Jing-Jing Zhang; Kui-Rong Jiang
Journal:  Cell Biosci       Date:  2021-05-13       Impact factor: 7.133

Review 3.  Long noncoding RNAs: role and contribution in pancreatic cancer.

Authors:  K T Ramya Devi; Dharshene Karthik; TharunSelvam Mahendran; M K Jaganathan; Sanjana Prakash Hemdev
Journal:  Transcription       Date:  2021-05-26

4.  The clinical significance of microRNA-409 in pancreatic carcinoma and associated tumor cellular functions.

Authors:  Kui Long; Qingbin Zeng; Wenzhi Dong
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.